Innovative Gastroenterologist to Lead Pediatric IBD Program
Dr. Michael Dolinger will lead the Pediatric Inflammatory Bowel Disease Program at NYU Langone's Hassenfeld Children’s Hospital.
Investigating the Role of Genes in Osteoarthritis Therapy
National Institutes of Health grant awarded to NYU Langone’s Dr. Steven Abramson to study genetic targets for osteoarthritis treatment.
Lupus Tied to Gut Microbiome
An NYU Langone study strongly suggests that in some patients, bacterial imbalances may be driving lupus and its associated disease flares.
New Therapies Improve Options for MS & Parkinson’s Patients
Novel treatment approaches by NYU Langone researchers could reduce symptoms and improve rehabilitation for patients with neurological disorders.
Newer Supermarkets Trim Childhood Obesity in New York City
An NYU Langone study shows that supermarket subsidies might play a role in addressing the complex problem of childhood obesity in America.
NYU Langone Health in the News— March 8, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from March 8, 2024.
NYU Langone Health in the News—June 26, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 26, 2024.
NYU Langone Hospital—Brooklyn Welcomes Dr. Jennifer Nishimura
NYU Langone Hospital—Brooklyn’s new chief of thoracic surgery is Dr. Jennifer M. Nishimura, an expert in minimally invasive and robotic thoracic surgery.
NYU Langone Research Leads to Bladder Cancer Drug Approval
NYU Langone research leads to FDA approval of new drug, pembrolizumab, to treat advanced bladder cancer.
Randomized Testing Helps Create a Learning Health System
A program at NYU Langone Health uses rapid-cycle, randomized testing to assess the effectiveness of patient-focused programs.